Pancreatic Cancers With ATM Defects May Respond to Irinotecan, Study Finds
A new study combining real-world clinical data with CRISPR-edited cell models shows that pancreatic cancers with ATM or CHEK2 mutations ...
A new study combining real-world clinical data with CRISPR-edited cell models shows that pancreatic cancers with ATM or CHEK2 mutations ...
In a groundbreaking study published recently in Nature Communications, a team of researchers led by Boonen, Knaup, and Menafra have ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine